Income Statement Avicanna Inc. OTC Markets

Stocks

AVCNF

CA05368K1003

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 10:13:46 2026-07-31 EDT			5-day change	1st Jan Change
0.0927 ^USD	+7.33%		-6.93%	-42.81%

07-16	Avicanna Launching Rapid Onset Medical Cannabis Portfolio in Canada	MT
07-16	Avicanna Introduces Quix Rapid-Onset Medical Cannabis Portfolio	CI

bb6ed86.xirpIJSMDUvmWXB2qdu6sZxzmqJ5U7oTkMGkiSqVRvk.rEmTbqTWRA7WGzQRzLP8__JBz_smYd58pJbT5lP9LYO2TNhN0sl-CLM6PQ

Published financial data: AVICANNA INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.27M	4.05M	16.79M	25.46M	25.48M
Total Revenues	3.27M	4.05M	16.79M	25.46M	25.48M
Cost of Goods Sold, Total	437K	2.93M	10.13M	12.56M	11.96M
Gross Profit	2.83M	1.12M	6.66M	12.9M	13.52M
Selling General & Admin Expenses, Total	11.87M	9.22M	11.89M	14.67M	14.2M
Provision for Bad Debts	169K	376K	430K	482K	183K
Stock-Based Compensation (IS)	1.31M	1.04M	1.94M	1.57M	1.17M
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	894K	887K	777K	854K	743K
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses, Total	14.25M	11.53M	15.04M	17.58M	16.3M
Operating Income	-11.41M	-10.41M	-8.38M	-4.68M	-2.78M
Interest Expense, Total	-738K	-1.67M	-610K	-334K	-51.84K
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-738K	-1.67M	-610K	-334K	-51.84K
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-77.42K	90.53K	-28.35K	472K	-35.45K
Other Non Operating Income (Expenses)	-84.92K	-102K	272K	925K	110K
EBT, Excl. Unusual Items	-12.31M	-12.09M	-8.75M	-3.62M	-2.76M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-338K	-	-	-	-
Gain (Loss) On Sale Of Assets	51.98K	-1.52M	2.81K	-665	-
Asset Writedown	-4.16M	-1.12M	-	-	-
EBT, Incl. Unusual Items	-16.76M	-14.74M	-8.74M	-3.62M	-2.76M
Income Tax Expense	13.77K	-	-	-	-
Earnings From Continuing Operations	-16.77M	-14.74M	-8.74M	-3.62M	-2.76M
Net Income to Company	-16.77M	-14.74M	-8.74M	-3.62M	-2.76M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-16.77M	-14.74M	-8.74M	-3.62M	-2.76M
Net Income to Common Incl Extra Items	-16.77M	-14.74M	-8.74M	-3.62M	-2.76M
Net Income to Common Excl. Extra Items	-16.77M	-14.74M	-8.74M	-3.62M	-2.76M
Per Share Items
Net EPS - Basic	-0.41	-0.25	-0.1	-0.04	-0.02
Basic EPS - Continuing Operations	-0.41	-0.25	-0.1	-0.04	-0.02
Basic Weighted Average Shares Outstanding	41.29M	59.17M	84.71M	100M	115M
Net EPS - Diluted	-0.41	-0.25	-0.1	-0.04	-0.02
Diluted EPS - Continuing Operations	-0.41	-0.25	-0.1	-0.04	-0.02
Diluted Weighted Average Shares Outstanding	41.29M	59.17M	84.71M	100M	115M
Normalized Basic EPS	-0.19	-0.13	-0.06	-0.02	-0.02
Normalized Diluted EPS	-0.19	-0.13	-0.06	-0.02	-0.02
Supplemental Items
EBITDA	-10.85M	-9.81M	-7.87M	-4.14M	-2.24M
EBITA	-11.34M	-10.38M	-8.32M	-4.54M	-2.64M
EBIT	-11.41M	-10.41M	-8.38M	-4.68M	-2.78M
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	3.27M	4.05M	16.79M	25.46M	25.48M
Effective Tax Rate - (Ratio)	-0.08	-	-	-	-
Total Current Taxes	-20.68K	-	-	-	-
Total Deferred Taxes	34.45K	-	-	-	-
Normalized Net Income	-7.7M	-7.56M	-5.47M	-2.26M	-1.72M
Interest on Long-Term Debt	364K	845K	115K	21.67K	3.46K
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
General and Administrative Expenses	11.87M	9.22M	11.89M	14.67M	14.2M
Research And Development Expense From Footnotes	304K	277K	331K	178K	256K
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	1.31M	1.04M	1.94M	1.57M	1.17M
Total Stock-Based Compensation	1.31M	1.04M	1.94M	1.57M	1.17M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	31K	1.19M	477K	448K	281K
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	31K	1.19M	477K	448K	281K
Accounts Receivable, Total	1.13M	2.12M	2.28M	2.39M	2.42M
Other Receivables	1.21M	27.75K	691K	358K	1.13M
Total Receivables	2.34M	2.15M	2.97M	2.75M	3.55M
Inventory	3M	3.11M	4.46M	3.93M	3.59M
Prepaid Expenses	901K	481K	471K	470K	222K
Other Current Assets, Total	1.08M	130K	83.18K	41.13K	254K
Total Current Assets	7.35M	7.06M	8.46M	7.64M	7.9M
Gross Property Plant And Equipment	16.33M	11.95M	14.32M	14.01M	15.83M
Accumulated Depreciation	-1.87M	-1.56M	-2.33M	-2.74M	-3.44M
Net Property Plant And Equipment	14.47M	10.39M	11.99M	11.27M	12.39M
Long-term Investments	180K	-	-	-	-
Goodwill	-	-	334K	334K	334K
Other Intangibles, Total	299K	168K	1.19M	869K	626K
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	22.3M	17.62M	21.97M	20.12M	21.24M
Liabilities
Accounts Payable, Total	7.29M	4.75M	8.87M	7.77M	8.51M
Short-term Borrowings	-	1.86M	-	-	-
Current Portion of Long-Term Debt	1.09M	797K	1.56M	-	-
Current Portion of Leases	156K	150K	150K	109K	-
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	-	-	-	416K	378K
Other Current Liabilities	3.66M	3.84M	1.39M	972K	292K
Total Current Liabilities	12.2M	11.41M	11.97M	9.27M	9.18M
Long-Term Debt	416K	180K	-	-	-
Long-Term Leases	-	222K	95.36K	-	-
Unearned Revenue Non Current	2.78M	2.35M	1.94M	1.11M	678K
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	15.39M	14.16M	14M	10.38M	9.86M
Common Stock, Total	66.24M	74.89M	81.03M	87M	88.26M
Retained Earnings	-77.41M	-90.83M	-98.71M	-102M	-105M
Comprehensive Income and Other	12.31M	15.55M	17.58M	17.4M	19.82M
Total Common Equity	1.15M	-384K	-113K	2.31M	2.84M
Minority Interest	5.76M	3.84M	8.08M	7.43M	8.54M
Total Equity	6.91M	3.46M	7.97M	9.74M	11.39M
Total Liabilities And Equity	22.3M	17.62M	21.97M	20.12M	21.24M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	53.41M	83.2M	92.29M	112M	126M
ECS Total Common Shares Outstanding	45.88M	74.95M	90.68M	110M	118M
Book Value / Share	0.02	-0.01	-0	0.02	0.02
Tangible Book Value	847K	-551K	-1.63M	1.11M	1.88M
Tangible Book Value Per Share	0.02	-0.01	-0.02	0.01	0.02
Total Debt	1.66M	3.21M	1.8M	109K	0
Net Debt	1.63M	2.02M	1.33M	-339K	-281K
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	5.76M	3.84M	8.08M	7.43M	8.54M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1M	602K	3.14M	2.48M	1.04M
Inventories - Work In Process, Total	370K	835K	1.73M	1.18M	477K
Inventories - Finished Goods, Total	605K	565K	2.47M	2.08M	1.66M
Inventories - Others	1.03M	1.11M	1.12M	829K	550K
Land - (BS)	7.79M	5.69M	6.92M	6.59M	7.4M
Machinery, Total	5.42M	4.35M	5.19M	5.03M	5.7M
Full Time Employees	124	80	87	87	112
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	659K	562K	278K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-16.77M	-14.74M	-8.74M	-3.62M	-2.76M
Depreciation & Amortization - CF	686K	739K	583K	536K	501K
Amortization of Goodwill and Intangible Assets - (CF)	70.15K	28.68K	59.86K	140K	140K
Depreciation & Amortization, Total	756K	768K	643K	676K	640K
Amortization of Deferred Charges, Total - (CF)	138K	120K	134K	178K	103K
Minority Interest in Earnings - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	1.52M	-	665	-
(Gain) Loss on Sale of Investments - (CF)	338K	-	-	-	-
Asset Writedown & Restructuring Costs	4.16M	1.12M	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	1.31M	1.04M	1.94M	1.57M	1.17M
Provision and Write-off of Bad Debts	169K	376K	430K	482K	183K
Other Operating Activities, Total	686K	922K	-168K	-1.05M	-463K
Change In Accounts Receivable	-1.5M	369K	-1.25M	-262K	-981K
Change In Inventories	-1.73M	-87.63K	1.16M	528K	-365K
Change In Accounts Payable	809K	-239K	4.39M	-1.1M	1.25M
Change In Income Taxes	-20.68K	-	-	-	-
Change in Other Net Operating Assets	-12.37K	1.39M	56.94K	42.39K	35.79K
Cash from Operations	-11.66M	-7.44M	-1.4M	-2.55M	-1.18M
Capital Expenditure	-769K	-50.72K	-44.62K	-403K	-256K
Sale of Property, Plant, and Equipment	300K	27.57K	17.96K	-	31
Cash Acquisitions	-	-	-2.51M	-	-
Divestitures	-	669K	-	-	-
Sale (Purchase) of Intangible assets	-20.06K	-16.06K	-513K	-	-
Investment in Marketable and Equity Securities, Total	1.25M	180K	-	-	-
Cash from Investing	761K	810K	-3.05M	-403K	-256K
Short Term Debt Issued, Total	-	2.23M	-	-	-
Long-Term Debt Issued, Total	2.36M	-	1.43M	-	-
Total Debt Issued	2.36M	2.23M	1.43M	-	-
Short Term Debt Repaid, Total	-68.12K	-	-1.06M	-	-
Long-Term Debt Repaid, Total	-1.41M	-1.41M	-922K	-1.83M	-113K
Total Debt Repaid	-1.47M	-1.41M	-1.98M	-1.83M	-113K
Issuance of Common Stock	6.87M	7.19M	2.83M	4.5M	1M
Other Financing Activities, Total	2.31M	1.89M	1.28M	737K	75.86K
Cash from Financing	10.06M	9.9M	3.55M	3.41M	963K
Foreign Exchange Rate Adjustments	-394K	-2.11M	180K	-487K	307K
Net Change in Cash	-1.24M	1.16M	-717K	-29.17K	-167K
Supplemental Items
Levered Free Cash Flow	-9.34M	-6.59M	-3.91M	-1.83M	-555K
Unlevered Free Cash Flow	-8.88M	-5.54M	-3.53M	-1.63M	-523K
Change In Net Working Capital	3.17M	900K	452K	724K	442K
Net Debt Issued / Repaid	885K	825K	-553K	-1.83M	-113K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-27.2	-32.6	-26.46	-13.9	-8.55
Return on Total Capital	-58.43	-85.4	-63.7	-29.81	-16.41
Return On Equity %	-161.16	-284.28	-152.97	-40.85	-26.17
Return on Common Equity	-468.41	-3.86K	3.52K	-328.83	-101
Margin Analysis
Gross Profit Margin %	86.63	27.55	39.66	50.66	53.06
SG&A Margin	363.11	227.78	70.8	57.62	55.75
EBITDA Margin %	-332.02	-242.41	-46.87	-16.26	-8.8
EBITA Margin %	-347	-256.47	-49.55	-17.83	-10.37
EBIT Margin %	-349.15	-257.18	-49.9	-18.38	-10.92
Income From Continuing Operations Margin %	-513.15	-364.02	-52.07	-14.21	-10.83
Net Income Margin %	-513.15	-364.02	-52.07	-14.21	-10.83
Net Avail. For Common Margin %	-513.15	-364.02	-52.07	-14.21	-10.83
Normalized Net Income Margin	-235.43	-186.72	-32.55	-8.88	-6.77
Levered Free Cash Flow Margin	-285.86	-162.76	-23.28	-7.2	-2.18
Unlevered Free Cash Flow Margin	-271.75	-136.95	-21	-6.38	-2.05
Asset Turnover
Asset Turnover	0.12	0.2	0.85	1.21	1.25
Fixed Assets Turnover	0.18	0.33	1.5	2.19	2.15
Receivables Turnover (Average Receivables)	3.56	2.49	9.22	10.91	10.59
Inventory Turnover (Average Inventory)	0.2	0.96	2.68	2.99	3.5
Short Term Liquidity
Current Ratio	0.6	0.62	0.71	0.82	0.86
Quick Ratio	0.19	0.29	0.29	0.34	0.42
Operating Cash Flow to Current Liabilities	-0.96	-0.65	-0.12	-0.27	-0.13
Days Sales Outstanding (Average Receivables)	102.66	146.6	39.6	33.55	34.46
Days Outstanding Inventory (Average Inventory)	1.79K	380.38	136.36	122.3	104.15
Average Days Payable Outstanding	1.17K	722.76	216.5	253.08	231.25
Cash Conversion Cycle (Average Days)	720.26	-195.78	-40.54	-97.23	-92.64
Long Term Solvency
Total Debt/Equity	24.06	92.8	22.62	1.12	-
Total Debt / Total Capital	19.39	48.13	18.45	1.11	-
LT Debt/Equity	6.02	11.61	1.2	-	-
Long-Term Debt / Total Capital	4.85	6.02	0.98	-	-
Total Liabilities / Total Assets	69.02	80.37	63.72	51.58	46.4
EBIT / Interest Expense	-15.46	-6.23	-13.73	-14.03	-53.68
EBITDA / Interest Expense	-14.44	-5.77	-12.68	-12	-41.32
(EBITDA - Capex) / Interest Expense	-15.48	-5.8	-12.75	-13.21	-46.26
Total Debt / EBITDA	-0.16	-0.33	-0.23	-0.03	-
Net Debt / EBITDA	-0.15	-0.21	-0.17	0.08	0.13
Total Debt / (EBITDA - Capex)	-0.15	-0.33	-0.23	-0.02	-
Net Debt / (EBITDA - Capex)	-0.14	-0.21	-0.17	0.08	0.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	108.2	23.83	314.82	51.62	0.08
Gross Profit, 1 Yr. Growth %	-596.71	-60.61	497.01	93.71	10.87
EBITDA, 1 Yr. Growth %	-40.39	-9.59	-19.57	-47.42	-56.03
EBITA, 1 Yr. Growth %	-39.94	-8.48	-19.66	-45.43	-51.98
EBIT, 1 Yr. Growth %	-39.89	-8.79	-19.51	-44.15	-50.69
Earnings From Cont. Operations, 1 Yr. Growth %	-48.95	-12.16	-40.67	-58.62	-39.75
Net Income, 1 Yr. Growth %	-48.95	-12.16	-40.67	-58.62	-39.75
Normalized Net Income, 1 Yr. Growth %	-44.29	-1.79	-27.68	-58.64	-39.74
Diluted EPS Before Extra, 1 Yr. Growth %	-63.65	-38.71	-58.56	-64.96	-47.47
Accounts Receivable, 1 Yr. Growth %	59.47	87.74	66.76	4.96	1.26
Inventory, 1 Yr. Growth %	135.26	3.6	43.43	-11.83	11.29
Net Property, Plant and Equip., 1 Yr. Growth %	-33.66	-28.21	15.43	-5.98	9.87
Total Assets, 1 Yr. Growth %	-26.04	-21	24.7	-8.44	9.42
Tangible Book Value, 1 Yr. Growth %	-84.65	-165.08	196.26	-167.97	32.89
Common Equity, 1 Yr. Growth %	-80.95	-133.46	-70.67	-2.16K	8.53
Cash From Operations, 1 Yr. Growth %	-16.52	-36.25	-81.11	81.39	-53.62
Capital Expenditures, 1 Yr. Growth %	-52.52	-93.41	-12.02	802.19	-36.44
Levered Free Cash Flow, 1 Yr. Growth %	21.15	-29.49	-40.68	-47.5	-68.96
Unlevered Free Cash Flow, 1 Yr. Growth %	17.68	-37.6	-36.38	-47.76	-66.92
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	340.78	60.57	126.64	150.79	23.18
Gross Profit, 2 Yr. CAGR %	454.38	39.87	53.34	240.07	42.49
EBITDA, 2 Yr. CAGR %	-30.48	-26.59	-14.84	-34.97	-46.62
EBITA, 2 Yr. CAGR %	-29.59	-25.86	-14.36	-33.79	-43.64
EBIT, 2 Yr. CAGR %	-29.9	-25.96	-14.32	-32.95	-42.38
Earnings From Cont. Operations, 2 Yr. CAGR %	-13.1	-33.04	-27.81	-50.45	-43.82
Net Income, 2 Yr. CAGR %	-13.1	-33.04	-27.81	-50.45	-43.82
Normalized Net Income, 2 Yr. CAGR %	-27.22	-26.03	-15.72	-45.31	-43.83
Diluted EPS Before Extra, 2 Yr. CAGR %	-38.76	-52.8	-49.6	-61.89	-51.73
Accounts Receivable, 2 Yr. CAGR %	71.36	73.03	41.96	32.3	3.09
Inventory, 2 Yr. CAGR %	42.21	56.12	21.9	12.46	-10.23
Net Property, Plant and Equip., 2 Yr. CAGR %	-20.96	-30.99	-8.97	4.18	1.63
Total Assets, 2 Yr. CAGR %	-29.73	-23.56	-0.74	6.85	-1.67
Tangible Book Value, 2 Yr. CAGR %	-67.7	-68.4	38.85	41.91	7.39
Common Equity, 2 Yr. CAGR %	-77.37	-74.75	-68.67	145.56	402.75
Cash From Operations, 2 Yr. CAGR %	-18.99	-27.05	-65.3	-41.47	-8.28
Capital Expenditures, 2 Yr. CAGR %	-68.83	-82.31	-75.91	181.74	139.46
Levered Free Cash Flow, 2 Yr. CAGR %	-19.18	-7.58	-35.33	-47.24	-60.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	-21.1	-14.3	-36.99	-45.86	-59.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	202.6	188.68	120.32	98.22	84.64
Gross Profit, 3 Yr. CAGR %	188.47	129.61	126.89	65.76	129.71
EBITDA, 3 Yr. CAGR %	9.47	-24.11	-24.39	-27.49	-38.8
EBITA, 3 Yr. CAGR %	10.45	-23.16	-23.91	-26.3	-36.57
EBIT, 3 Yr. CAGR %	10.56	-23.47	-23.87	-25.71	-35.59
Earnings From Cont. Operations, 3 Yr. CAGR %	32.02	-12.79	-35.68	-40.03	-42.79
Net Income, 3 Yr. CAGR %	33.19	-12.79	-35.68	-40.03	-42.79
Normalized Net Income, 3 Yr. CAGR %	14.91	-19.57	-26.59	-33.53	-38.89
Diluted EPS Before Extra, 3 Yr. CAGR %	-8.04	-38.74	-54.8	-55.35	-54.12
Accounts Receivable, 3 Yr. CAGR %	116.36	76.66	47.57	28.37	21.02
Inventory, 3 Yr. CAGR %	-	27.96	51.77	9.43	4.94
Net Property, Plant and Equip., 3 Yr. CAGR %	-3.81	-23.46	-18.08	-7.98	6.04
Total Assets, 3 Yr. CAGR %	-10.77	-26.93	-10.02	-3.38	6.43
Tangible Book Value, 3 Yr. CAGR %	-42.12	-59.2	-33.36	9.43	50.61
Common Equity, 3 Yr. CAGR %	-60.29	-74.22	-73.46	26.37	94.99
Cash From Operations, 3 Yr. CAGR %	32.7	-25.21	-53.5	-39.78	-45.84
Capital Expenditures, 3 Yr. CAGR %	-41.63	-81.43	-69.8	-19.41	71.51
Levered Free Cash Flow, 3 Yr. CAGR %	8.03	-22.77	-20.28	-41.89	-56.16
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.23	-27.03	-22.4	-43.23	-54.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	173.07	169.56	172.88	74.6
Gross Profit, 5 Yr. CAGR %	-	111.01	124.04	168.67	88.37
EBITDA, 5 Yr. CAGR %	-	31.22	-0.99	-28.7	-34.22
EBITA, 5 Yr. CAGR %	99.61	32.17	-0.23	-27.64	-32.52
EBIT, 5 Yr. CAGR %	99.85	32.12	-0.16	-27.41	-31.89
Earnings From Cont. Operations, 5 Yr. CAGR %	115.85	41.48	3.7	-30.44	-39.07
Net Income, 5 Yr. CAGR %	115.85	41.48	4.25	-30.44	-39.07
Normalized Net Income, 5 Yr. CAGR %	102.91	36	1.51	-31.07	-34.04
Diluted EPS Before Extra, 5 Yr. CAGR %	-5.29	-2.88	-27.7	-49.34	-53.6
Accounts Receivable, 5 Yr. CAGR %	-	256.39	82.8	44.09	27.85
Inventory, 5 Yr. CAGR %	-	-	-	21.52	23.01
Net Property, Plant and Equip., 5 Yr. CAGR %	-	86.46	-5.91	-13.41	-10.7
Total Assets, 5 Yr. CAGR %	199.21	52.77	-6.89	-14.93	-6.77
Tangible Book Value, 5 Yr. CAGR %	95.36	-4.98	-17.86	-32.83	-19.35
Common Equity, 5 Yr. CAGR %	107.55	-14.53	-63.88	-36.49	-13.92
Cash From Operations, 5 Yr. CAGR %	120.72	28.36	-22.4	-32.19	-38.99
Capital Expenditures, 5 Yr. CAGR %	-	-37.03	-59.03	-44.88	-30.87
Levered Free Cash Flow, 5 Yr. CAGR %	-	52.89	-12.01	-33.69	-40.92
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	47.7	-13.8	-35.24	-41.38